Purchase Order 75N91020P00569
- Not listed
- This purchase order awards Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division $580,350.05 to deliver one Becton Dickson FACSympony A5 flow cytometer or equivalent to the National Cancer Institute's Center for Cancer Research Vaccine Branch located in Bethesda, Maryland by January 28, 2021. The solicitation sought quotes for a replacement high-parameter flow cytometer with specific laser and detector capabilities to support the National Institutes of Health National...
- This is a firm-fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for the provision of twelve flow cytometers and twenty-nine lasers. The contract has a base year period of performance from January 21, 2019 to January 20, 2020, with one optional one-year renewal period. The potential value of the contract is...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to Becton, Dickinson and Company (BD), a major medical technology company. The $79,171.34 firm fixed-price purchase order is for an upgrade to a BD Biosciences Fortessa flow cytometer. Flow cytometers are critical instruments used in biomedical research and clinical applications supported by the NCI. This award is associated with a larger BD Biosciences contract vehicle, likely an Indefinite...
- This is a $99,717.48 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD). The contract is for the provision of three LSR FORTESSA flow cytometers with laser systems, as well as an annual service agreement. There is no set-aside designation for this award. BD is a major manufacturer of medical devices, instruments, and supplies, including...
- This is a $750,000.00 firm fixed price purchase order contract awarded by the National Cancer Institute to Becton, Dickinson & Co (BD) for a special order BD Biosciences LSRFortessa X-30 flow cytometer. The contract has no set-aside designation. BD is a manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical laboratories, pharmaceutical companies, and the general public. BD has received numerous federal contract awards as...
- This is a $126,090.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Becton, Dickinson and Company (BD) for a service contract to provide an LSRFortessa flow cytometer with lasers. The contract does not have a set-aside designation. BD, a large medical technology and manufacturing company, will deliver the flow cytometry instrument to support research activities at the NIH...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) to acquire a BD FACSymphony A3 flow cytometer analyzer, a five-laser, 23-color system. The contract, which did not have a set-aside designation, was awarded on September 20, 2019 with a completion date of January 20, 2020 and a potential value of $359,443.75. BD Biosciences, a division of BD focused on...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson And Company (BD) for the delivery of flow cytometric equipment. The contract has a ceiling value of $379,693.50 and an ultimate completion date of August 26, 2016. The contract was not set aside for any specific business type. BD is a global medical technology company that provides a wide range of goods and services to U.S. government agencies,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the purchase of a LSRFORTESSA flow cytometry system. The $699,999.00 firm fixed-price purchase order did not utilize a set-aside. BD, a global medical technology company, has extensive experience providing specialized biomedical research equipment and consumables to federal agencies...
- This firm fixed-price contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) to provide a new flow cytometer system configured per the quote. The contract has a potential value of $772,218.37 and a completion date of February 9, 2023. The contract was awarded on September 18, 2019 and was not set aside for any specific business type. BD is a...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Becton, Dickinson and Company for the delivery of specialized flow cytometers. The solicitation sought to replace outdated equipment at the Experimental Immunology Branch Flow Cytometry Facility with new Becton Dickinson models customized to meet the technical laser excitation and fluorescence detector configurations required to maintain compatibility with existing research protocols and reagents. Valued at approximately $578,679, the award will provide one LSRFortessa X20 3-laser and one LSRFortessa X20 5-laser flow cytometer to the facility by December 2020 in support of ongoing immunology research projects. No subcontractors or set aside designations were identified.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Becton Dickinson Special Order LSRFortessa X20 3-laser Flow Cytometer and 5-laser Flow Cytometer | 75N91020Q00085 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Special Notice 1/1 | 6/12/20, 2:38 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $578.7k | 9/14/20 |